Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Inventory (2016 - 2025)

Standard Biotools (LAB) has disclosed Inventory for 16 consecutive years, with $42.1 million as the latest value for Q1 2025.

  • On a quarterly basis, Inventory changed N/A to $42.1 million in Q1 2025 year-over-year; TTM through Mar 2025 was $42.1 million, a N/A change, with the full-year FY2024 number at $20.7 million, changed N/A from a year prior.
  • Inventory was $42.1 million for Q1 2025 at Standard Biotools, up from $20.7 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $42.1 million in Q1 2025 to a low of $20.7 million in Q4 2024.
  • A 5-year average of $25.4 million and a median of $22.7 million in 2022 define the central range for Inventory.
  • Biggest YoY gain for Inventory was 58.73% in 2022; the steepest drop was 9.11% in 2022.
  • Standard Biotools' Inventory stood at $20.8 million in 2021, then skyrocketed by 58.73% to $33.1 million in 2022, then tumbled by 33.2% to $22.1 million in 2023, then fell by 6.05% to $20.7 million in 2024, then skyrocketed by 103.07% to $42.1 million in 2025.
  • Per Business Quant, the three most recent readings for LAB's Inventory are $42.1 million (Q1 2025), $20.7 million (Q4 2024), and $22.1 million (Q2 2023).